FDA Inspection 982472 — Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site)

Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site) — FEI 3003011617

The FDA completed an inspection of Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site) on July 15, 2016 in Hanzhong. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 15, 2016
Fiscal Year
2016
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Hanzhong (China)